Zobrazeno 1 - 3
of 3
pro vyhledávání: '"MESH: Nitrosourea Compounds"'
Autor:
Vauleon, Elodie, Mesbah, Habiba, Gedouin, Daniel, Lecouillard, Isabelle, Louvel, Guillaume, Hamlat, Abderrahmane, Riffaud, Laurent, Carsin, Béatrice, Quillien, Véronique, Audrain, Odile, Lesimple, Thierry
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, John Libbey Eurotext, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, John Libbey Eurotext, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
International audience; Despite progress in the initial management of glioblastoma (GB), the vast majority of patients will experience recurrence within 2-3 years. The medical treatment of these recurrences is being modified by the use of antiangioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b62f758d962f7570da705007e28c72a1
https://www.hal.inserm.fr/inserm-00662493
https://www.hal.inserm.fr/inserm-00662493
Autor:
Michel Arock, Lionel Devevey, Philippe Helissey, Jean-Jacques Guillosson, Joëlle Nafziger, Pascale Chrétien, Natacha Bernard, Céline Jacquemont
Publikováno v:
Experimental Hematology
Experimental Hematology, Elsevier, 2005, 33 (10), pp.1130-9. ⟨10.1016/j.exphem.2005.06.018⟩
Experimental Hematology, 2005, 33 (10), pp.1130-9. ⟨10.1016/j.exphem.2005.06.018⟩
Experimental Hematology, Elsevier, 2005, 33 (10), pp.1130-9. ⟨10.1016/j.exphem.2005.06.018⟩
Experimental Hematology, 2005, 33 (10), pp.1130-9. ⟨10.1016/j.exphem.2005.06.018⟩
OBJECTIVE: Although B acute lymphoblastic leukemia (B-ALL) is the most common leukemia among children, no chemically inducible model of this leukemia has yet been described in vivo. METHODS: Leukemia was chemically induced in male WKAH/Hkm rats by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84bc03c6ddbfa92a0b4e1b21e5f4db47
https://pubmed.ncbi.nlm.nih.gov/16219535
https://pubmed.ncbi.nlm.nih.gov/16219535
Autor:
Emilie Thivat, Xavier Durando, Anne Sinsard, Michel D'Incan, Philippe Chollet, Jean-Claude Madelmont
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2005, 5, pp.147. ⟨10.1186/1471-2407-5-147⟩
BMC Cancer, Vol 5, Iss 1, p 147 (2005)
BMC Cancer, BioMed Central, 2005, 5, pp.147. ⟨10.1186/1471-2407-5-147⟩
BMC Cancer, Vol 5, Iss 1, p 147 (2005)
Background Median survival of metastatic malignant melanoma is 6.0 to 7.5 months, with a 5-year survival of ~6.0%. Although long-term complete remissions are rare, few reports describe cases after chemotherapy. Fifty-three patients with metastatic me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43310885b46ca755a5c83da7f4f3cbcf